Effect of γ-ethyl-γ-phenyl-butyrolactone (EFBL), anticonvulsant and hypnotic drug, on mouse brain catecholamine levels

Rasgado, Lourdes A. Vega; Villanueva, Iván; Díaz, Fernando Vega

doi:10.1515/acph-2017-0014

.blurhash-client-img { display: none !important; }

Effect of γ-ethyl-γ-phenyl-butyrolactone (EFBL), anticonvulsant and hypnotic drug, on mouse brain catecholamine levels

Acta Pharmaceutica

Volume 67 (2017): Issue 2 (June 2017)

By: Lourdes A. Vega Rasgado, Iván Villanueva and Fernando Vega Díaz

Open Access

|Jun 2017

Authors

Lourdes A. Vega Rasgado

lourdes_vega_rasgado@hotmail.com

Laboratorio de Neuroquímica Departamento de Bioquímica Escuela Nacional de Ciencias Biológica Instituto Politécnico Nacional Carpio y Plan de Ayala S/N Colonia Casco de Santo Tomás C.P. 11340,, México, México

Iván Villanueva

Departamento de Fisiología Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala S/N Colonia Casco de Santo Tomás C.P. 11340,, México, México

Fernando Vega Díaz

DOI: https://doi.org/10.1515/acph-2017-0014 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 215 - 226

Accepted on: Dec 16, 2016

Published on: Jun 1, 2017

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

γ-ethyl-γ-phenyl-butyrolactone (EFBL),

Related subjects:

© 2017 Lourdes A. Vega Rasgado, Iván Villanueva, Fernando Vega Díaz, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 67 (2017): Issue 2 (June 2017)Next article